{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Princeton",
      "state": "NJ",
      "country": "United States",
      "classification": "Class I",
      "openfda": {
        "application_number": [
          "ANDA212918"
        ],
        "brand_name": [
          "ATOVAQUONE"
        ],
        "generic_name": [
          "ATOVAQUONE"
        ],
        "manufacturer_name": [
          "Bionpharma Inc."
        ],
        "product_ndc": [
          "69452-252"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "ATOVAQUONE"
        ],
        "rxcui": [
          "308429"
        ],
        "spl_id": [
          "4523911f-9d9c-4b0c-e063-6394a90ac76d"
        ],
        "spl_set_id": [
          "bff4f4fc-6307-f414-e053-2a95a90ac0de"
        ],
        "package_ndc": [
          "69452-252-87"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0369452252871"
        ],
        "nui": [
          "N0000175482",
          "N0000175485"
        ],
        "pharm_class_epc": [
          "Antimalarial [EPC]",
          "Antiprotozoal [EPC]"
        ],
        "unii": [
          "Y883P1Z2LT"
        ]
      },
      "product_type": "Drugs",
      "event_id": "95345",
      "recalling_firm": "Bionpharma Inc.",
      "address_1": "400 Alexander Park Ste 2-4b",
      "address_2": "",
      "postal_code": "08540-6539",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide in the U.S.A.",
      "recall_number": "D-0012-2025",
      "product_description": "Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, NDC # 69452-252-87.",
      "product_quantity": "1,980 bottles",
      "reason_for_recall": "Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.",
      "recall_initiation_date": "20240917",
      "center_classification_date": "20241015",
      "termination_date": "20250916",
      "report_date": "20241023",
      "code_info": "Lot # 2310083, Exp. 09/30/2025",
      "more_code_info": ""
    }
  ]
}